Contributions of two UDP-glucose dehydrogenases to viability and polymyxin B resistance of Burkholderia cenocepacia

Microbiology

Volumn 155, Issue 6, 2009, Pages 2029-2039

  Loutet, Slade A ^a   Bartholdson, S Josefin ^b,c   Govan, John R W ^b   Campopiano, Dominic J ^c   Valvano, Miguel A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMODIMER; NICOTINAMIDE ADENINE DINUCLEOTIDE; POLYMYXIN B; URIDINE DIPHOSPHATE GLUCOSE; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE; URIDINE DIPHOSPHATE GLUCURONIC ACID; ANTIINFECTIVE AGENT; BACTERIAL RNA; HYBRID PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERIUM MUTANT; BURKHOLDERIA CENOCEPACIA; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME PURIFICATION; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; GENE MUTATION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; AMINO ACID SEQUENCE; BIOSYNTHESIS; BURKHOLDERIA CEPACIA; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENETICS; METABOLISM; MOLECULAR GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BURKHOLDERIA CENOCEPACIA;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION; GENETIC COMPLEMENTATION TEST; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; POLYMYXIN B; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

EID: 67650756921     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.027607-0     Document Type: Article

References (43)

1. Aaron, S. D., Ferris, W., Henry, D. A., Speert, D. P. & Macdonald, N. E. (2000). Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 161, 1206-1212.
2. Aubert, D. F., Flannagan, R. S. & Valvano, M. A. (2008). A novel sensor kinase-response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia. Infect Immun 76, 1979-1991.
3. Bader, M. W., Sanowar, S., Daley, M. E., Schneider, A.R., Cho, U., Xu, W., Klevit, R. E., Le Moual, H. & Miller, S. I. (2005). Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122, 461-472.
4. Balandreau, J., Viallard, V., Cournoyer, B., Coenye, T., Laevens, S. & Vandamme, P. (2001). Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl Environ Microbiol 67, 982-985.
5. Breazeale, S. D., Ribeiro, A. A. & Raetz, C. R. (2002). Oxidative decarboxylation of UDP-glucuronic acid in extracts of polymyxin-resistant Escherichia coli. Origin of lipid A species modified with 4-amino-4-deoxy-L-arabinose. J Biol Chem 277, 2886-2896.
6. Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3, 238-250.
7. Burns, J. L., Wadsworth, C. D., Barry, J. J. & Goodall, C. P. (1996). Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother 40, 307-313.
8. Campbell, R. E., Mosimann, S. C., van De Rijn, I., Tanner, M. E. & Strynadka, N. C. (2000). The first structure of UDP-glucose dehydrogenase reveals the catalytic residues necessary for the two-fold oxidation. Biochemistry 39, 7012-7023.
9. De Leon, G. P., Elowe, N. H., Koteva, K. P., Valvano, M. A. & Wright, G. D. (2006). An in vitro screen of bacterial lipopolysaccharide biosynthetic enzymes identifies an inhibitor of ADP-heptose biosynthesis. Chem Biol 13, 437-441.
10. Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M. & Miller, S. I. (1999). Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286, 1561-1565.
11. Figurski, D. H. & Helinski, D. R. (1979). Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A 76, 1648-1652.
12. Flannagan, R. S., Aubert, D., Kooi, C., Sokol, P. A. & Valvano, M. A. (2007). Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo. Infect Immun 75, 1679-1689.
13. Flannagan, R. S., Linn, T. & Valvano, M. A. (2008). A system for the construction of targeted unmarked gene deletions in the genus Burkholderia. Environ Microbiol 10, 1652-1660.
14. Ganz, T. (2003). Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3, 710-720.
15. Ge, X., Penney, L. C., van de Rijn, I. & Tanner, M. E. (2004). Active site residues and mechanism of UDP-glucose dehydrogenase. Eur J Biochem 271, 14-22.
16. Gold, R., Jin, E., Levison, H., Isles, A. & Fleming, P. C. (1983). Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother 12 (Suppl A), 331-336.
17. 31P-NMR study. Mol Microbiol 11, 481-487.
18. Hitchcock, P. J. & Brown, T. M. (1983). Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 154, 269-277.
19. Holden, M. T., Seth-Smith, H. M., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., Thomson, N. R., Bason, N., Quail, M. A. & other authors (2009). The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 191, 261-277.
20. Hung, R. J., Chien, H. S., Lin, R. Z., Lin, C. T., Vatsyayan, J., Peng, H. L. & Chang, H. Y. (2007). Comparative analysis of two UDP-glucose dehydrogenases in Pseudomonas aeruginosa PAO1. J Biol Chem 282, 17738-17748.
21. Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P. & Levison, H. (1984). Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104, 206-210.
22. Iwanicka-Nowicka, R., Zielak, A., Cook, A. M., Thomas, M. S. & Hryniewicz, M. M. (2007). Regulation of sulfur assimilation pathways in Burkholderia cenocepacia: identification of transcription factors CysB and SsuR and their role in control of target genes. J Bacteriol 189, 1675-1688.
23. Kox, L. F., Wösten, M. M. & Groisman, E. A. (2000). A small protein that mediates the activation of a two-component system by another two-component system. EMBO J 19, 1861-1872.
24. Loutet, S. A., Flannagan, R. S., Kooi, C., Sokol, P. A. & Valvano, M. A. (2006). A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 188, 2073-2080.
25. Mahenthiralingam, E., Coenye, T., Chung, J. W., Speert, D. P., Govan, J. R., Taylor, P. & Vandamme, P. (2000). Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38, 910-913.
26. Mahenthiralingam, E., Urban, T. A. & Goldberg, J. B. (2005). The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3, 144-156.
27. McPhee, J. B., Lewenza, S. & Hancock, R. E. (2003). Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50, 205-217.
28. 2+-induced gene regulation in Pseudomonas aeruginosa. J Bacteriol 188, 3995-4006.
29. Miller, V. L. & Mekalanos, J. J. (1988). A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170, 2575-2583.
30. Moreira, L. M., Videira, P. A., Sousa, S. A., Leitäo, J. H., Cunha, M. V. & Sá-Correia, I. (2003). Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem Biophys Res Commun 312, 323-333.
31. Mouslim, C. & Groisman, E. A. (2003). Control of the Salmonella ugd gene by three two-component regulatory systems. Mol Microbiol 47, 335-344.
32. Nummila, K., Kilpelainen, I., Zähringer, U., Vaara, M. & Helander, I. M. (1995). Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol 16, 271-278.
33. Ortega, X. P., Cardona, S. T., Brown, A. R., Loutet, S. A., Flannagan, R. S., Campopiano, D. J., Govan, J. R. & Valvano, M. A. (2007). A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability. J Bacteriol 189, 3639-3644.
34. Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V. & Hancock, R. E. (2002). Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother 46, 605-614.
35. Raetz, C. R. & Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu Rev Biochem 71, 635-700.
36. Rossman, M. G. (1981). Evolution of glycolytic enzymes. Philos Trans R Soc Lond B Biol Sci 293, 191-203.
37. Silipo, A., Molinaro, A., Cescutti, P., Bedini, E., Rizzo, R., Parrilli, M. & Lanzetta, R. (2005). Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide. Glycobiology 15, 561-570.
38. Strominger, J. L., Maxwell, E. S., Axelrod, J. & Kalckar, H. M. (1957). Enzymatic formation of uridine diphosphoglucuronic acid. J Biol Chem 224, 79-90.
39. Turner, J., Cho, Y., Dinh, N. N., Waring, A. J. & Lehrer, R. I. (1998). Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42, 2206-2214.
40. Vaara, M., Vaara, T., Jensen, M., Helander, I., Nurminen, M., Rietschel, E. T. & Mäkelä, P. H. (1981). Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett 129, 145-149.
41. Wösten, M. M. S. M., Kox, L. F. F., Chamnongpol, S., Soncini, F. C. & Groisman, E. A. (2000). A signal transduction system that responds to extracellular iron. Cell 103, 113-125.
42. Zanetti, M. (2004). Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75, 39-48.
43. Zhang, L., Parente, J., Harris, S. M., Woods, D. E., Hancock, R. E. & Falla, T. J. (2005). Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother 49, 2921-2927.